Indian Energy Exchange Q3 Results 2025 show a revenue increase of 14.53% YoY and a profit increase of 16.86% YoY, with profit ...

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma major posted a ...

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...

Indian benchmark indices faced losses led by PSU banks and pharma stocks, while Power Grid and ICICI Bank gained. Wall Street ...

Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.

Today, majors including DLF, Interglobe Aviation, Godrej Consumer Products, NIIT, DCB Bank, Bank of India, others are ...

Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...

Dr Reddy’s shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE).

IST, the barometer index, the S&P BSE Sensex rose 144.40 points or 0.19% to 76,678.04. The Nifty 50 index added 49.30 points or 0.21% to 23,254.65.

Dr. Reddy's shares are the top losers on the Nifty 50 index today. Out of the 40 analysts that have coverage on Dr. Reddy's, 15 of them have a 'Buy' rating, while 15 of them have a 'Sell' call. The ...